Haleon: Investor education event – Oral Health

Haleon today is hosting Haleon Highlights, its first mini deep dive educational event on its Oral Health category in London. The event will be hosted by Jayant Singh, Head of Global Oral Health and Adam Sisson, Head of R&D for Global Oral Health.

The event will outline Haleon’s Oral Health business, its leading brands and market position, in the growing therapeutic segment, and the opportunities for penetration and geographic expansion which we believe will drive continued outperformance over the medium term.

No new material financial information or trading information will be disclosed.

The event which will also be webcast, starts at 2.30pm GMT and the presentation will be added to the website shortly before it starts. Registration details and other information can be found at:

https://www.haleon.com/investors.

A replay of the event will be posted to the website afterwards.

Enquiries

About Haleon plc

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information please visit www.haleon.com